neisseria
meningitidi
caus
mening
epidem
worldwid
rapidli
progress
fatal
septic
shock
crucial
step
pathogenesi
invas
meningococc
infect
adhes
bloodborn
meningococci
peripher
brain
endothelia
lead
major
vascular
dysfunct
initi
adhes
pathogen
strain
endotheli
cell
reli
meningococc
type
iv
pili
endotheli
receptor
bacteri
adhes
remain
unknown
report
immunoglobulin
superfamili
member
also
call
extracellular
matrix
metalloproteinas
induc
emmprin
basigin
critic
host
receptor
meningococc
pilu
compon
pile
pilv
interf
interact
potent
inhibit
primari
attach
meningococci
human
endotheli
cell
vitro
prevent
colon
vessel
human
brain
tissu
explant
ex
vivo
human
mice
vivo
find
establish
molecular
event
meningococci
target
human
endothelia
open
new
perspect
treatment
prevent
meningococcusinduc
vascular
dysfunct
npg
n
meningitidi
also
refer
meningococcu
oblig
human
gramneg
bacterium
normal
resid
nasopharyng
mucosa
without
affect
host
phenomenon
known
carriag
patholog
initi
meningococci
gain
access
bloodstream
multipli
blood
dissemin
variou
tissu
caus
mening
purpura
fulminan
sever
form
meningococc
invas
diseas
despit
antimicrobi
therapi
system
meningococc
infect
remain
major
caus
mortal
sever
neurolog
sequela
endothelium
line
blood
lymphat
vessel
key
barrier
separ
circul
bodi
fluid
host
tissu
major
target
sever
pathogen
bacteria
crucial
step
pathophysiolog
invas
bloodborn
meningococci
adhes
prolifer
peripher
brain
blood
microvessel
process
refer
vascular
colon
intim
interact
meningococci
endotheli
cell
lead
deregul
inflammatori
coagul
process
endotheli
dysfunct
ultim
breach
endotheli
barrier
bacteri
dissemin
perivascular
tissu
deciph
mechan
govern
initi
pathophysiolog
step
invas
meningococc
diseas
repres
essenti
develop
toward
design
new
therapeut
approach
control
bacteri
infect
subsequ
vascular
tissu
damag
capac
pathogen
capsul
meningococci
interact
tightli
human
endotheli
cell
reli
express
type
iv
pili
howev
host
cell
adhes
receptor
mediat
bacteri
attach
human
vessel
remain
unknown
type
iv
pili
long
filament
structur
extend
bacteri
cell
surfac
mediat
adhes
endotheli
cell
signal
event
eventu
lead
bacteri
transloc
endothelia
structur
heteromultimer
assembl
pilin
subunit
form
helic
fiber
major
pilin
subunit
pile
constitut
essenti
fiber
scaffold
subject
antigen
variat
less
abund
minor
pilin
pilv
pilx
comp
structur
resembl
pile
particip
variou
pilusrel
function
adhes
bacteri
aggreg
dna
uptak
respect
pile
pilv
shown
involv
adhes
host
cell
furthermor
two
pilin
recent
report
activ
g
proteincoupl
adrenerg
receptor
ar
promot
endotheli
signal
event
subsequ
bacteri
adhes
howev
ardeplet
endotheli
cell
although
unabl
promot
signal
event
still
support
pilusmedi
bacteri
adhes
thu
indic
primari
meningococc
attach
requir
anoth
yet
unidentifi
host
receptor
type
iv
pili
report
member
immunoglobulin
ig
superfamili
receptor
type
iv
pilusmedi
adhes
pathogen
meningococci
human
brain
peripher
endotheli
cell
interact
major
minor
pilinspil
pilvand
establish
central
role
vascular
colon
meningococci
vivo
candid
endotheli
receptor
meningococci
identifi
candid
receptor
initi
attach
piliat
capsul
meningococci
use
gainoffunct
strategi
cell
dedifferenti
human
brain
endotheli
cell
line
transform
papilloma
viru
poorli
permiss
meningococc
adhes
basal
condit
treatment
cell
phorbol
ester
tpa
potent
transcript
regul
induc
enhanc
adhes
meningococcu
strain
supplementari
fig
treatment
transcript
inhibitor
actinomycin
block
tpa
effect
suggest
regul
express
put
receptor
tpa
transcript
level
supplementari
fig
expect
type
iv
pilusmedi
adhes
nonpili
meningococc
pilenul
mutant
fail
adher
tpatreat
cell
supplementari
fig
order
identifi
upregul
gene
permiss
cell
use
differenti
quantit
largescal
analysi
gene
express
onlin
method
show
gene
upregul
tpa
among
analyz
gene
six
encod
membraneassoci
protein
supplementari
tabl
among
four
protein
either
limit
tissu
distribut
sialic
acidbind
igtyp
lectin
siglec
siglec
deltaand
notchlik
epiderm
growth
factorrel
receptor
locat
mainli
brain
limit
surfac
exposur
phosphatidylethanolaminebind
protein
therefor
instead
focus
type
plasma
membran
protein
member
ig
superfamili
wellestablish
marker
brain
capillari
glycosylphosphatidylinositolanchor
glycoprotein
known
inhibit
membran
attack
complex
format
complement
cascad
induc
signal
event
confirm
tpa
treatment
cell
upregul
express
supplementari
fig
express
enrich
site
meningococc
adhes
wherea
supplementari
fig
investig
relev
endotheli
candid
receptor
meningococc
adhes
use
two
fulli
differenti
human
endotheli
cell
line
isol
either
brain
bone
marrow
human
bone
marrow
endotheli
cell
hbmec
capillari
observ
tpatreat
cell
recruit
site
meningococc
adhes
hbmec
supplementari
fig
noninfect
fulli
polar
hbmec
monolay
enrich
cellcel
junction
engag
homophil
interact
also
present
lumin
surfac
fig
supplementari
fig
upon
infect
accumul
site
meningococc
adhes
cell
fig
hbmec
supplementari
fig
alreadi
observ
signal
ar
receptor
accumul
occur
rapidli
upon
contact
diplococci
cell
surfac
fig
independ
recruit
ar
expect
receptor
mediat
initi
adhes
fig
supplementari
fig
thu
seem
potenti
endotheli
receptor
candid
n
meningitidi
establish
role
meningococc
adhes
transfect
endotheli
cell
sirna
reduct
surfac
express
cell
hbmec
respect
correl
decreas
meningococc
adhes
cerebr
peripher
endotheli
cell
respect
fig
b
data
support
rescu
meningococc
adhes
endotheli
cell
fig
convers
increas
express
hbmec
increas
bacteri
adher
fig
specif
deplet
affect
bacteri
adhes
hbmec
supplementari
fig
furthermor
deplet
intercellular
adhes
two
membraneassoci
molecul
recruit
site
bacteri
adhes
upon
type
iv
pilusmedi
signal
event
affect
meningococc
adhes
either
cell
hbmec
supplementari
fig
aim
approach
physiolog
condit
shear
stress
encount
human
blood
microvasculatur
infect
endotheli
cell
meningococci
control
laminar
flow
chamber
enabl
quantif
initi
bacteri
contact
endotheli
cell
surfac
observ
attenu
express
cell
reduc
number
initi
adhes
event
fig
confirm
dynam
condit
select
effect
deplet
meningococc
adhes
pathogen
meningococci
belong
differ
capsular
group
show
great
capac
antigen
variat
pile
gene
alter
type
iv
pilusmedi
primari
adhes
host
cell
therefor
perform
adhes
experi
use
meningococc
strain
belong
differ
capsular
serogroup
serogroup
serogroup
b
serogroup
c
rou
serogroup
fig
well
deriv
serogroup
c
display
differ
variant
major
pilin
subunit
pile
design
pile
sa
pile
sb
fig
reduct
express
affect
adhes
differ
strain
variant
similarli
demonstr
capac
support
type
iv
pilusdepend
adhes
independ
capsular
antigen
antigen
variat
pile
competit
experi
solubl
recombin
chimer
molecul
contain
extracellular
domain
fuse
fc
domain
human
show
caus
reduct
bacteri
adhes
hbmec
cell
wherea
solubl
effect
fig
confirm
extracellular
portion
bind
site
meningococci
assay
two
antibodi
specif
respect
bind
extracellular
ntermin
ctermin
ig
domain
interact
inhibitor
supplementari
fig
antibodi
label
noninfect
cell
similarli
supplementari
fig
effici
label
molecul
recruit
bacteri
adhes
site
suggest
antibodi
meningococci
compet
bind
site
ctermin
ig
domain
supplementari
fig
accordingli
preincub
cell
hbmec
antibodi
infect
inhibit
initi
attach
shear
stress
respect
wherea
antibodi
reduc
initi
attach
fig
overal
data
indic
critic
receptor
primari
attach
piliat
meningococci
peripher
brain
human
endotheli
cell
next
investig
whether
interact
meningococcu
direct
perform
meningococc
adhes
experi
use
recombin
immobil
glass
coverslip
meningococci
adher
type
iv
pilusdepend
manner
immobil
noncoat
control
well
fig
identifi
bacteri
pilu
compon
involv
interact
use
escherichia
coli
produc
minor
pilin
pilv
pilx
comp
well
two
variant
major
pilin
pile
pile
sa
pile
sb
fusion
protein
maltosebind
protein
mbp
pile
variant
pilv
fusion
protein
reduc
adhes
piliat
capsul
meningococci
competit
assay
wherea
pilx
comp
effect
fig
assess
direct
interact
pilin
use
sever
complementari
approach
first
purifi
pile
sb
pilv
recombin
pilin
immobil
inactiv
staphylococci
could
select
pull
solubl
fig
second
proteinprotein
interact
assay
base
oxygen
singlet
transfer
alphascreen
detect
dosedepend
associ
pile
sb
pilv
minor
pilin
fig
e
interact
independ
antigen
variat
pile
subunit
supplementari
fig
specif
supplementari
fig
observ
meningococc
adhes
human
endotheli
cell
interact
inhibit
antibodi
control
antibodi
fig
supplementari
fig
npg
third
use
surfac
plasmon
reson
found
specif
interact
pile
sb
pilvcoat
staphylococci
immobil
supplementari
fig
observ
interact
use
monomer
pilin
data
shown
result
indic
despit
rel
low
affin
pile
sb
pilv
monom
cluster
staphylococci
provid
suffici
avid
consist
multimer
organ
pilin
within
pilu
fiber
quantifi
interact
pile
variant
pilv
atom
forc
microscopi
afm
fig
observ
loaddepend
correl
interact
forc
pile
variant
pilv
confirm
specif
interact
data
shown
measur
interact
forc
pn
pn
pn
pile
sa
pile
sb
pilv
respect
twofold
lower
establish
ligand
cyclophilin
pn
data
consist
previous
describ
role
pile
pilv
neisseria
speci
pilusmedi
adhes
host
cell
confirm
direct
particip
pile
pilv
select
interact
meningococci
establish
role
pile
pilv
meningococc
adhes
endotheli
cell
use
defect
strain
neither
nonpili
piliat
pilvnul
mutant
abl
adher
vitro
hbmec
cell
fig
control
complement
strain
recov
bacteri
adhes
endotheli
cell
line
effici
correl
express
level
complement
protein
supplementari
fig
investig
specif
role
pile
pilv
endotheli
colon
meningococci
vivo
human
specif
pathogen
colon
mous
vessel
use
human
mous
model
sever
combin
immunodefici
scid
mice
graft
human
skin
function
human
blood
vessel
maintain
within
graft
although
limit
dermal
vessel
model
constitut
uniqu
tool
studi
meningococc
interact
human
endotheli
cell
realist
condit
live
host
previous
shown
h
bacteri
challeng
wildtyp
strain
massiv
colon
human
dermal
vasculatur
type
iv
pilusdepend
manner
observ
colon
nonpili
deriv
fig
c
consist
vitro
observ
meningococc
deriv
associ
vessel
graft
human
skin
fig
c
wherea
complement
strain
colon
human
vessel
effici
correl
express
level
complement
protein
supplementari
fig
result
establish
pile
pilv
essenti
bacteri
compon
vivo
type
iv
pilusmedi
vascular
colon
analyz
select
interact
meningococci
use
situ
meningococc
infect
model
fresh
npg
human
frontal
brain
tissu
obtain
deceas
normal
subject
set
histolog
anatom
characterist
brain
vessel
conserv
meningococci
incub
tissu
section
establish
specif
tight
associ
brain
vessel
predominantli
virchowrobin
space
cortic
region
fig
supplementari
fig
reminisc
neuropatholog
find
patient
meningococc
mening
adhes
reli
express
pile
pilv
mutant
adher
poorli
fig
supplementari
fig
upon
infect
wildtyp
meningococci
develop
microcoloni
immedi
adjac
endotheli
cell
fig
also
found
meningococci
vicin
leptomening
cell
cortic
brain
vessel
supplementari
fig
b
associ
glial
neuron
cell
express
supplementari
fig
indic
close
correl
meningococc
adhes
fresh
human
brain
tissu
express
consist
vitro
cellular
model
pretreat
brain
section
antibodi
substanti
reduc
adhes
meningococci
human
brain
vessel
wherea
antibodi
control
antibodi
effect
fig
c
altogeth
data
confirm
type
iv
pilusmedi
adhes
meningococcu
necessari
endotheli
cell
colon
bacteri
pathogen
studi
demonstr
specif
interact
meningococc
ligand
pile
pilv
cellular
host
receptor
essenti
meningococc
adhes
human
endotheli
cell
colon
human
blood
vessel
prerequisit
major
vascular
alter
hallmark
invas
meningococc
infect
result
help
unravel
molecular
basi
key
pathophysiolog
step
meningococc
diseas
consist
previou
report
suggest
addit
structur
role
pilu
scaffold
pile
subunit
play
direct
role
bacteri
adhes
host
cell
pilv
also
previous
shown
requir
adhes
close
relat
neisseria
gonorrhoea
interact
occur
independ
antigen
variat
pile
subunit
possibl
posttransl
modif
pile
pilv
rel
low
affin
wherea
multimer
pilin
effici
bind
indic
system
avid
crucial
consist
natur
organ
pilin
multimer
complex
within
pilu
fiber
endotheli
cell
particularli
brain
microvessel
express
high
level
like
express
level
may
also
contribut
avid
compens
weak
affin
pilin
interact
two
pilu
compon
act
concert
creat
adhes
phenotyp
remain
solv
identif
precis
pile
pilv
epitop
requir
interact
allow
develop
target
antibodi
could
prevent
type
iv
interact
open
path
new
vaccin
strategi
meningococc
infect
express
differ
cell
type
erythrocyt
epitheli
cell
pilusdepend
interact
meningococci
erythrocyt
caus
hemagglutin
document
vitro
meningococci
describ
cross
polar
epithelia
indic
meningococcu
might
interact
varieti
cell
type
notabl
sever
virus
includ
sever
acut
respiratori
syndrom
coronaviru
measl
viru
well
bacteri
pathogen
listeria
monocytogen
also
target
adher
andor
invad
epitheli
cell
indic
constitut
evolutionarili
conserv
effici
target
pathogen
infect
tissu
spread
within
organ
also
known
emmprin
master
regul
product
matrix
metalloproteinas
therefor
like
addit
role
pathogen
adhes
invas
process
also
contribut
disrupt
epitheli
endotheli
barrier
integr
promot
local
product
matrix
metalloproteinas
wherea
express
requir
support
bacteri
adhes
endotheli
cell
brain
peripher
origin
ar
express
necessari
meningococcustrigg
signal
ar
dispens
adhes
meningococc
adhes
prerequisit
activ
signal
pathway
thu
suggest
ar
might
cooper
strengthen
meningococc
adhes
promot
subsequ
activ
signal
event
notabl
similar
function
associ
two
receptor
report
context
erythrocyt
infect
human
parasit
plasmodium
falciparum
agent
malaria
although
mechan
associ
still
unknown
implic
two
receptor
differ
tissu
context
differ
infecti
diseas
might
reflect
preexist
function
connect
ar
hijack
differ
pathogen
dissemin
induc
multipl
organ
failur
npg
taken
togeth
data
highlight
key
role
cascad
pathophysiolog
event
follow
meningococc
entri
bloodstream
agent
vaccin
prevent
type
iv
pilu
interact
might
therefor
highli
effect
treatment
prevent
meningococc
infect
associ
vascular
dysfunct
method
associ
refer
avail
onlin
version
paper
mab
clone
purchas
abd
serotec
mab
clone
mem
tebubio
mab
clone
immunotech
mab
clone
r
system
antihuman
collagen
iv
clone
abcam
antigfap
clone
antivimentin
clone
sigmaaldrich
polyclon
antiserum
rais
ezrin
obtain
p
mangeat
mab
rais
pile
polyclon
antiserum
rais
meningococc
strain
describ
previous
secondari
antibodi
use
immunofluoresc
label
chromogen
immunohistochemistri
immunoblot
jackson
immunoresearch
laboratori
solubl
chimer
molecul
purchas
r
system
dapi
rhodaminephalloidin
tpa
actinomycin
isoproterenol
dab
peroxidas
substrat
nbtbcip
phosphatas
alkalin
substrat
purchas
sigmaaldrich
bacteri
strain
formerli
clone
piliat
capsul
opa
opcvari
serogroup
c
meningococc
clinic
isol
ref
cultur
describ
previous
express
pilin
variant
pile
sa
pile
sb
gfp
previous
describ
pilv
mutant
engin
introduct
resist
cassett
pilv
gene
complement
pilv
mutant
pilv
allel
amplifi
use
primer
pilv
forward
pilv
revers
contain
overhang
restrict
site
paci
pcr
fragment
restrict
paci
clone
pacirestrict
vector
describ
place
pilv
transcript
control
iptg
induc
promot
within
dna
fragment
correspond
intragen
region
meningococc
chromosom
pilv
construct
introduc
chromosom
mutant
homolog
recombin
similar
scheme
use
construct
complement
pile
isogen
meningococcu
strain
orf
pile
gene
insert
e
coli
paci
restrict
site
plasmid
primer
use
amplifi
pile
pile
forward
pile
revers
induc
pile
construct
insert
ectop
chromosom
strain
transform
use
erythromycin
select
wildtyp
pile
locu
subsequ
inactiv
transform
chromosom
dna
previous
describ
inactiv
endogen
deriv
select
kanamycin
virtual
pile
could
detect
absenc
induct
result
strain
wherea
induct
yield
approxim
wildtyp
express
level
pile
pile
one
strongli
constitut
express
meningococc
protein
phenotyp
despit
low
level
pile
complement
induc
upon
iptg
treatment
function
type
iv
pili
express
upon
pile
complement
ascertain
restor
compet
compet
frequenc
per
dna
pile
wildtyp
strain
respect
cell
line
fulli
differenti
human
brain
endotheli
cell
line
deriv
brain
capillari
produc
laboratori
recapitul
major
phenotyp
featur
bloodbrain
barrier
hbmec
human
endotheli
cell
line
isol
bone
marrow
capillari
provid
b
weksler
maintain
vitro
characterist
primari
endotheli
cell
human
brain
endotheli
cell
line
transform
papilloma
viru
provid
ja
nelson
lost
phenotyp
featur
brain
endotheli
cell
cell
cultur
transfect
infect
induc
bacteri
adhes
cell
treat
phorbol
ester
tpa
ng
ml
min
wash
bacteri
adhes
measur
h
treatment
indic
h
tpa
treatment
transcript
inhibitor
actinomycin
ad
ml
h
cell
wash
adhes
measur
h
later
hbmec
cell
line
cultur
transfect
infect
previous
describ
plasmid
encod
human
provid
bukrinski
plasmid
encod
adrenerg
receptor
fuse
yfp
aryfp
describ
previous
silenc
express
ar
pool
four
sirna
duplex
ontarget
plu
smartpool
sirna
dharmacon
use
sicontrol
sirna
dharmacon
use
control
h
transfect
effici
knockdown
assess
fac
analysi
reversepcr
analysi
ar
deplet
previous
describ
indic
hbmec
cell
transfect
sirna
target
untransl
region
control
sirna
eurogentech
h
later
cell
either
mock
transfect
transfect
cdna
code
region
h
later
surfac
express
quantifi
fac
analysi
cell
infect
concurr
serial
analysi
gene
express
adapt
downsiz
extract
rna
extract
untreat
tpatreat
cell
h
treatment
tpa
use
substrat
serial
analysi
gene
express
adapt
downsiz
extract
sade
screen
carri
describ
briefli
total
rna
extract
cell
polyadenyl
rna
select
oligodt
column
tag
cdna
synthes
polya
rna
concatem
dna
tag
sequenc
number
sequenc
tag
differenti
repres
two
librari
determin
analyz
use
mont
carlo
statist
analysi
adhes
assay
static
flow
condit
meningococc
adhes
hbmec
cell
assay
static
shear
stress
condit
previous
describ
indic
meningococci
preincub
ml
solubl
recombin
human
chimera
interact
hbmec
cell
addit
ml
solubl
protein
meningococc
adhes
quantifi
follow
infect
static
condit
address
inhibitori
effect
antibodi
hbmec
cell
grown
ibidi
chamber
pretreat
h
ml
antibodi
target
submit
laminar
flow
dynescm
invert
microscop
gfpexpress
bacteria
introduc
chamber
flow
min
number
adher
bacteria
determin
previous
describ
adhes
assay
immobil
protein
chimera
immobil
glass
slide
use
modif
techniqu
describ
briefli
slide
coat
polyllysin
wash
pb
crosslink
glutaraldehyd
wash
incub
antifc
assay
buffer
pb
bsa
h
wash
assay
buffer
incub
overnight
ml
chimer
protein
slide
wash
infect
meningococc
suspens
od
incub
bacteria
slide
wash
three
time
fix
bacteria
label
visual
leica
microscop
use
oilimmers
object
number
adher
bacteria
per
field
quantifi
field
use
imagej
softwar
express
purif
immobil
maltosebind
proteinpilin
recombin
protein
purifi
pilin
produc
fusion
protein
maltosebind
protein
mbp
describ
fragment
pile
sa
sb
pilv
pilx
comp
lack
region
code
amino
acid
residu
fulllength
protein
fuse
mbp
produc
e
coli
purifi
amylos
resin
new
england
biolab
immobil
staphylococcu
aureu
atcc
express
specif
receptor
fc
domain
igg
describ
coat
bacteria
incub
chimera
min
ice
wash
bacteria
lyse
laemmli
buffer
quantiti
coprecipit
protein
assess
immunoblot
analysi
bound
quantifi
use
imagej
softwar
indic
cell
pretreat
ml
mbppilin
min
infect
meningococc
suspens
od
min
incub
bacteria
cell
npg
